Lung Cancer

Conference Coverage
Greater Immune Protection Against SARS-CoV-2 Needed in Lung Cancer Therapy
09/10/2021
An ongoing cohort study found that although most lung cancer patients have displayed promising antibody responses to SARS-CoV-2 vaccinations, a subgroup exhibited significantly lower antibody/neutralizing levels, indicating further studies...
An ongoing cohort study found that although most lung cancer patients have displayed promising antibody responses to SARS-CoV-2 vaccinations, a subgroup exhibited significantly lower antibody/neutralizing levels, indicating further studies...
An ongoing cohort study found...
09/10/2021
Oncology
News
Selpercatinib Superior to Prior Systemic Therapy in RET-Positive NSCLC
06/22/2021
Patients with RET-positive NSCLC who received selpercatinib therapy had a better overall response than those who received prior systemic therapy, according to findings from the phase 1/2 LIBRETTO-001 trial.
Patients with RET-positive NSCLC who received selpercatinib therapy had a better overall response than those who received prior systemic therapy, according to findings from the phase 1/2 LIBRETTO-001 trial.
Patients with RET-positive NSCLC...
06/22/2021
Oncology
News
Sotorasib Safe, Effective for KRAS p.G12C-mutated NSCLC
06/10/2021
Sotorasib therapy demonstrated durable efficacy with manageable safety for previously treated KRAS p.G12C-mutated NSCLC.
Sotorasib therapy demonstrated durable efficacy with manageable safety for previously treated KRAS p.G12C-mutated NSCLC.
Sotorasib therapy demonstrated...
06/10/2021
Oncology
Videos
Dr Bruno Highlights Racial Disparities in Testing, Trial Enrollment in NSCLC
06/07/2021
Dr Bruno, MD, discusses the racial disparities in biomarker testing and clinical trial enrollment in patients with NSCLC.
Dr Bruno, MD, discusses the racial disparities in biomarker testing and clinical trial enrollment in patients with NSCLC.
Dr Bruno, MD, discusses the...
06/07/2021
Oncology
Ongoing Trial Will Assess Trastuzumab Deruxtecan–Pembrolizumab Combo for Breast Cancer, NSCLC
Videos
Ongoing Trial Will Assess Trastuzumab Deruxtecan–Pembrolizumab Combo for Breast Cancer, NSCLC
05/27/2020
Hope Rugo, MD, looks forward to the safety and efficacy findings of an ongoing study examining trastuzumab deruxtecan plus pembrolizumab for breast cancer and NSCLC.
Hope Rugo, MD, looks forward to the safety and efficacy findings of an ongoing study examining trastuzumab deruxtecan plus pembrolizumab for breast cancer and NSCLC.
Hope Rugo, MD, looks forward to...
05/27/2020
Oncology

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use